Edition:
Deutschland

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

92.30EUR
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
€92.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
494,760
52-wk High
€96.61
52-wk Low
€74.54

MRCG.DE

Chart for MRCG.DE

About

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnol... (more)

Buy/Sell

Sell Hold Buy
2.33 Mean rating from 27 analysts

Overall

Beta: 1.01
Market Cap(Mil.): €12,352.97
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.26

UPDATE 1-Stada, buyout funds in race for Bristol-Myers' French business - sources

LONDON, Oct 8 German generic drugmaker Stada is vying with a group of European buyout funds for control of Bristol-Myers Squibb's French over-the-counter drugs business, sources familiar with the matter told Reuters.

Stada, buyout funds in race for Bristol-Myers' French business - sources

LONDON, Oct 8 German generic drugmaker Stada is vying with a group of European buyout funds for control of Bristol-Myers Squibb's French over-the-counter drugs business, sources familiar with the matter told Reuters.

German stocks - Factors to watch on Sept. 24

FRANKFURT/BERLIN, Sept 24 The following are some of the factors that may move German stocks on Monday:

Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer

FRANKFURT, Sept 11 Merck KGaA said that its immunotherapy Bavencio, jointly developed with Pfizer , delayed the progression of kidney cancer when used in combination with Pfizer's Inlyta drug in a late-stage study.

UPDATE 1-Germany tells drugmakers to check supply chains for no-deal Brexit risks

* German regulator seeking information from drug industry groups

Germany tells drugmakers to check supply chains for no-deal Brexit risks

FRANKFURT, Aug 29 German drugmakers have been asked by the government to examine their supply chains for any vulnerability that could cause shortages of essential drugs in the event that Britain leaves the European Union without a Brexit deal.

Deals of the day-Mergers and acquisitions

Aug 28 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

EU mergers and takeovers (Aug 28)

BRUSSELS, Aug 28 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Photo

EU clears $3.9 billion P&G deal for German Merck's consumer health business unit

BRUSSELS EU antitrust regulators have approved Procter & Gamble's (P&G) 3.4 billion euro ($3.9 billion) acquisition of Merck KGaA's consumer health unit, saying on Tuesday that they had no competition concerns.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.26%
Rohstoffe -0.28%
Industrie -0.03%
Konjunktur abhängige Waren & Dienstleistungen -0.12%
Konjunktur unabhängige Waren & Dienstleistungen -0.01%
Finanzindustrie -0.00%
Pharma -0.03%
Technologie -0.04%
Telekommunikation +0.04%